Vimarsana
Biggest News Aggregation in the World

Alchemab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alchemab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alchemab Today - Breaking & Trending Today

Alchemab Therapeutics: Alchemab Selected to Access NVIDIA Cambridge-1 Supercomputer to Advance Machine Learning Enabled Antibody Discovery - Vimarsana News

Alchemab Therapeutics: Alchemab Selected to Access NVIDIA Cambridge-1 Supercomputer to Advance Machine Learning Enabled Antibody Discovery

Alchemab Therapeutics, a biotechnology company focused on the discovery and development of naturally-occurring protective antibodies and immune repertoire-based patient stratification tools, has been

Alchemab to Collaborate With AstraZeneca to Use Alchemab's Drug Discovery Platform for Prostate Cancer Study - Vimarsana News

Alchemab to Collaborate With AstraZeneca to Use Alchemab's Drug Discovery Platform for Prostate Cancer Study

Proof-of-concept immuno-oncology collaboration with AstraZeneca to build understanding of prostate cancer Alchemab's advanced analytics to be used to analyse patient immune responses, identify

Alchemab And AstraZeneca Collaborate On Prostate Cancer Research - Vimarsana News

Alchemab And AstraZeneca Collaborate On Prostate Cancer Research

AstraZeneca (AZN) is collaborating with biotech company Alchemab on prostate cancer research. The two companies will work on a proof-of-concept study to develop insights into prostate cancer. The collaboration will make use of Alchemab’s drug discovery platform to identify disease biomarkers that can help in developing therapeutics based on novel antibodies. Alchemab CSO, Dr. Jane Osbourn said, “Our collaboration with AstraZeneca is a great opportunity to showcase Alchemab’s novel technology, not only as a drug discovery engine for new therapeutics but also as a potential ...

Source: yahoo.com
Alchemab and Medicines Discovery Catapult to develop landmark novel antibody therapy for Huntington's disease - Vimarsana News

Alchemab and Medicines Discovery Catapult to develop landmark novel antibody therapy for Huntington's disease

Alchemab and Medicines Discovery Catapult to develop landmark novel antibody therapy for Huntington's disease Alchemab using unique approach to explore adaptive immunity identifying naturally protective antibodies in 'resilient patients' to specific diseases Innovate UK Grant to support the finding of a disease-modifying therapy for Huntington's disease (HD), a degenerative disease with no cure and no therapies to prevent progression Alchemab is working in collaboration with Medicines Discovery Catapult, a not-for-profit, government-funded organisation supporting UK life science innovators H...